Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The interplay between cellular membranes, reactive oxygen species (ROS), and polyunsaturated fatty acids (PUFAs) in retinal cells is a critical factor in retinal health and disease [Beatty et al., 2000]. Retinal cells, particularly photoreceptors, contain high concentrations of PUFAs like docosahexaenoic acid (DHA) within their outer segment membranes, which are essential for maintaining the fluidity required for rapid phototransduction [SanGiovanni & Chew, 2005]. However, these membranes are highly susceptible to lipid peroxidation due to the high oxygen tension, constant light exposure, and the presence of photosensitizers in the retina. ROS-mediated damage to these lipids leads to the formation of toxic byproducts like 4-hydroxynonenal (4-HNE) and the accumulation of lipofuscin in the retinal pigment epithelium (RPE) [Sparrow et al., 2012]. This process is a primary driver of degenerative conditions such as age-related macular degeneration (AMD) and Stargardt disease. Therapeutic strategies focus on neutralizing ROS with antioxidants or reinforcing PUFAs against oxidation using deuterated analogs (D-PUFAs) to maintain membrane integrity and cell viability [Heidt et al., 2020].
Antioxidants neutralize reactive oxygen species (ROS) to prevent the initiation of lipid peroxidation. Deuterated polyunsaturated fatty acids (D-PUFAs) stabilize carbon-hydrogen bonds against abstraction by free radicals, thereby inhibiting the chain reaction of lipid peroxidation in retinal membranes.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cellular membranes, reactive oxygen species, and polyunsaturated fatty acids in retinal cells.